Response Pharmaceuticals

Falls Church, VA · Founded 2021 · Privately Held (backing)

Developer an intestinal microsomal triglyceride transfer protein inhibitor designed to treat the metabolic side effects of antipsychotic drugs. Response Pharmaceuticals is based in Falls Church, VA and was founded in 2021. It was valued at $30 million at its early-stage round in Nov 2025, the last priced event on record. It has raised $16.9 million across 2 recorded rounds; the latest was a $3.9 million debt round in Jun 2024.

PMV mark · valuation
$30.0M
Oct 2026
Priced at
its early-stage round
Nov 2025
Total raised
$16.9M
Last round
Debt
Jun 2024

Who backs Response Pharmaceuticals?

6 investors
InvestorType
Evolution VC PartnersVenture capital
CrossWorkVenture capital
Collage Venture Partners—
K2X—
Momentum Biotech—
Transhuman Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Response Pharmaceuticals investors

6 investors are on record for Response Pharmaceuticals, including Evolution VC Partners, CrossWork, Collage Venture Partners and K2X. The debt round in Jun 2024 drew 51 investors.

Free account
More of Response Pharmaceuticals with a free account
  • ·Watch Response Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Response Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View